References
- Ozawa H, Saitou H, Mizutari K, Takata Y, Ogawa K. Hypothyroidism after radiotherapy for patients with head and neck cancer. Am. J. Otolaryngol. 28(1), 46–49 (2007).
- Jemal A, Murray T, Ward E et al. Cancer statistics, 2005. CA Cancer J. Clin. 55(1), 10–30 (2005).
- Vidal L, Gillison ML. Human papillomavirus in HNSCC: Recognition of a distinct disease type. Hematol. Oncol. Clin. N. Am. 22, 1125–1142 (2008).
- Chaturvedi AK, Engels EA, Pfeiffer RM et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J. Clin. Oncol. 29, 4294–4301 (2011).
- Fakhy C, Westra H, Li S et al. Improved survival of patient s with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J. Natl Cancer Inst. 100, 261–269 (2008).
- Lassen P, Eriksen JG, Hamilton-Dutoit S et al. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. J. Clin. Oncol. 27(12), 1992–1998 (2009).
- Posner MR, Lorch JH, Goloubeva O et al. Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international Phase III trial. Ann. Oncol. 22(5), 1071–1077 (2011).
- Rischin D, Young RJ, Fisher R et al. Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 Phase III trial. J. Clin. Oncol. 28(27), 4142–4148 (2010).
- Jereczek-Fossa BA, Alterio D, Jassem J et al. Radiotherapy-induced thyroid disorders. Cancer Treat. Rev. 30(4), 369–384 (2004).
- Mini S, Dori S, Horowitz Z et al. Pretreatment prevalence of hypothyroidism in patients with head and neck carcinoma. Cancer 92, 1512–1515 (2001).
- Bakhshandeh M, Hashemi B, Mahdavi SRM et al. Normal tissue complication probability modeling of radiation-induced hypothyroidism after head-and-neck therapy. Int. J. Radiation Oncol. Biol. Phys. 85(2), 514–521 (2013).
- Miller MC, Agrawal A. Hypothyroidism in postradiation head and neck cancer patients: incidence, complications and management. Curr. Opin. Otolaryngol. Head Neck Surg. 17, 111–115 (2009).
- Koc M, Capoglu I. Thyroid dysfunction in patients treated with radiotherapy for neck. Am. J. Clin. Oncol. 32(2), 150–153 (2009).
- Bolling T, Geisenheiser A, Pape H et al. Hypothyroidism after head-and-neck radiotherapy in children and adolescents: preliminary results of the “Results for the Evaluation of Side Effects After Radiotherapy in Childhood and Adolescence” (RiSK). Int. J. Radiat. Oncol. Biol. Phys. 81(5), e787–e791 (2011).
- Hancock SL, McDougall IR, Constine LS. Thyroid abnormalities after therapeutic external radiation. Int. J. Radiat. Oncol. Biol. Phys. 31(5), 1165–1170 (1995).
- Gui A, Faaruq S, Abbasi NZ et al. Estimation of absorbed dose to thyroid in patients treated with radiotherapy for various cancers. Radiat. Prot. Dosimetry. 156(1), 37–41 (2013).
- Boomsma MJ, Bijl HP, Langendijk JA. Radiation-induced hypothyroidism in head and neck cancer patients: a systemic review. Radiother. Oncol. 99(1), 1–5 (2011).
- Boomsma MJ, Bijl HP, Christianen ME et al. A prospective cohort study on radiation-induced hypothyroidism: development of an NTCP model. Int. J. Radiat. Oncol. Biol. Phys. 84(3), e351–e356 (2012).
- Cella L, Liuzzi R, Conson M et al. Development of multivariate NTCP models for radiation-induced hypothyroidism: a comparative analysis. Radiat. Oncol. 7, 224 (2012).
- Lin Z, Wu VWC, Lin J, Feng H, Chen L. A longitudinal study on radiation-induced thyroid gland changes after external beam radiotherapy of nasopharyngeal carcinoma. Thyroid 21(1), 19–23 (2011).
- Miller-Thomas MM, Kumar AJ, Sellin RV, Azimpoor S, Ang KK. The shrinking thyroid: How does thyroid size change following radiation therapy for laryngeal cancer? Am. J. Neuroradiol. 30, 613–616 (2009).
- Chougule A, Kochar B. Thyroid dysfunction following therapeutic external radiation to head and neck cancer. Asian Pacific J. Cancer Prev. 12(11), 443–445 (2011).
- Nishiyama K, Tanaka E, Tarui Y et al. A prospective analysis of subacute thyroid dysfunction after neck irradiation. Int. J. Radiat. Oncol. Biol. Phys. 34(2), 439–434 (1996).
- Smith GL, Smith BD, Garden AS et al. Hypothyroidism in older patients with head and neck cancer after treatment with radiation: A population-based study. Head Neck 31, 1031–1038 (2009).
- Kanti AR, Ranjan DA, Santanu P et al. Iatrogenic hypothyroidism: a consequence of external beam radiotherapy to the head & neck malignancies. J. Cancer Res. Ther. 1(3), 142–146 (2005).
- Munyo-Estefan A, Lopez-Paullier M, Charlone-Granucci R et al. Thyroid function alteration in patients with radiation therapy. Acta Otorrinolaringol. Esp. 60(4), 268–271 (2009).
- Cetinayak O, Akman F, Kentli S et al. Assessment of treatment-related thyroid dysfunction in patients with head and neck cancer. Tumori 94(1), 19–23 (2008).
- Diaz R, Jaboin JJ, Morales-Paliza M et al. Hypothyroidism as a consequence of intensity-modulated radiotherapy with concurrent taxane-based chemotherapy for locally advanced head-and-neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 77(2), 468–476 (2010).
- Mercado G, Adelstein DJ, Saxton JP et al. Hypothyroidism: A frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma. Cancer 92, 2892–2897 (2001).
- Vogelius IR, Bentzen SM, Maraldo MV, Peterson PM, Specht L. Risk factors for radiation-induced hypothyroidism. Cancer 117, 5250–5260 (2011).
- Darzy KH, Shalet SM. Hypopituitarism following radiotherapy revisited. Endocr. Dev. 15, 1–24 (2009).
- Darzy KH, Murray RD, Gleeson HK et al. The impact of short-term fasting on the dynamics of 24-hour growth hormone (GH) secretion in patients with severe radiation-induced GH deficiency. J. Clin. Endocrinol.Metab. 91, 987–994 (2006).
- Siala W, Mnejja W, Abid M et al. Thyroid toxicity after radiotherapy of nasopharyngeal carcinoma. Ann. Endocrinol. (Paris) 72(1), 19–23 (2011).
- Bhandare N, Kennedy L, Malyapa RS, Morris CG, Mendehall WM. Hypopituitarism after radiotherapy for extracranial head and neck cancers in pediatric patients. Am. J. Clin.Oncol. 31(6), 567–572 (2008).
- Nishi Y, Hamamoto K, Fijita N, Okada S. Empty sella/pituitary atrophy and endocrine impairments as a consequence of radiation and chemotherapy in long-term survivors of childhood leukemia. Int. J. Hematol. 94(4), 399–402 (2011).
- Ron E, Lubin JH, Shore RE et al. Thyroid cancer after exposure to external radiation: A pooled analysis of seven studies. Radiat. Res. 178(2), AV43–AV60 (2012).
- Veiga LHS, Lubin JH, Anderson H et al. A pooled analysis of thyroid cancer incidence following radiotherapy for childhood cancer. Radiat. Res. 178, 365–376 (2012).
- Mabuchi K, Hatch M, Little MP, Linet MS, Simon SL. Risk of thyroid cancer after adult radiation exposure: Time to re-assess? Radiat. Res. 179, 254–256 (2013).
- Kovalchik SA, Ronckers CM, Veiga LH et al. Absolute risk prediction of second primary thyroid cancer among 5-year survivors of childhood cancer. J. Clin. Oncol. 31(1), 119–127 (2013).
- Rose J, Wertheim BC, Guerrero MA. Radiation treatment of patients with primary pediatric malignancies: risk of developing thyroid cancer as a secondary malignancy. Am. J. Surg. 204(6), 881–887 (2012).
- Vivanco M, Dalle JH, Alberti C et al. Malignant and benign thyroid nodules after total body irradiation preceding hematopoietic cell transplantation during childhood. Eur. J. Endocrinol. 167(2), 225–233 (2012).
- Massimino M, Gandola L, Mattavelli F et al. Radiation-induced thyroid changes: a retrospective and a prospective view. Eur. J. Cancer 45(14), 2546–2551 (2009).
- Sassolas GM, Hafdi-Nejjari Z, Casgranda L et al. Thyroid cancers in children, adolescents, and young adults with and without a history of childhood exposure to therapeutic radiation for cancers. Thyroid 23(7), 805–810 (2013).
- Cooper DS, Doherty GM, Haugen BR et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association (ATA) guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 19(11), 1167–1214 (2009).
- de Bree R, Lips P, Leemans CR. The need for patients’ endocrine function vigilance following treatment of head and neck cancer. Curr. Opin. Otolaryngol. Head Neck Surg. 16(2), 154–157 (2008).
Website
- National Comprehensive Care Network. (NCCN) clinical practice guidelines in oncology. Head Neck Cancers Version (2013). www.nccn.org/professionals/physician_gls/recently_updated.asp